Times Herald-Record News Article- Baltia Air Lines

New Post Public Reply Private Reply Replies (0) Message Board
MOJO JOJO
880
Times Herald-Record News Article- Baltia Air Lines spokesman John Lampl said the company is now auditing Songbird Airways' assets and liabilities to determine if it wants to proceed with the acquisition. Baltia hope to fly out of Stewart International Airport under the name USGlobal Airways.

Baltia Air Lines, the aspirational company that plans to use Stewart Airport as a hub for new international cargo and passenger service, wants to buy an already licensed carrier to speed the federal approval process to operate.

In a June 23 filing with the Securities and Exchange Commission, Baltia reported that it had signed a non-binding letter of intent to purchase Songbird Airways for $6.2 million and had made a deposit of $1 million with an escrow agent.

Songbird, based in Coral Gables, Fla., is licensed by the U.S. Department of Transportation and Federal Aviation Administration to conduct domestic and international charter operations with up to 10 aircraft. It owns a single Boeing 737-400, a plane that was released in the 1980s and that other airlines have largely retired.

John Lampl, a Baltia spokesman, said the company is now auditing Songbird’s assets and liabilities to determine if it wants to proceed with the acquisition. Then, the DOT and FAA will have to sign off on the sale and transfer of Songbird’s certification to Baltia.

“It’s early days but it’s moving along,″ said Lampl.

Tony Koulouris, Baltia’s president, told shareholders at a May 11 meeting at Stewart that the company was considering buying another airline to fast-track its application for certification but would need $50 million to cover start-up costs regardless.

He listed London; Paris; Barcelona, Spain; Nice, France; Naples, Italy; Athens, Greece; Warsaw, Poland; Budapest, Hungary; Prague, Czechoslovakia; St. Petersburg, Russia; and Tel Aviv, Israel, as among the first destinations for the airline once it begins operations.

Songbird was originally known as Sky King, after the National Basketball Association’s Sacramento Kings, and founded to fly the team. After two bankruptcy filings in the past five years, the company was purchased by shareholders and rebranded. It announced it would consider offers in 2015.

In another SEC filing last month, Baltia said the audited financial statements for the fiscal year ending Dec. 31, 2015, that was filed on April 14, 2016, “should no longer be relied upon.” The statements, the last ones available for the company, showed assets of $1.7 million and liabilities of $5 million.

Baltia explained that a review of its finances as part of the transition to the new management team led by Koulouris in late 2016 revealed a failure to account for payments to Logistic Air Inc. for the lease of airplane engines. It pledged to bring its financial reporting current as soon as practicable.

In the interim, Baltia and Logistic are in settlement negotiations over an $8.8 million bill.

The company also reported that shareholder voting had concluded June 9 on the two proposals that Koulouris presented May 11: changing Baltia’s name to USGlobal Airways and effecting a reverse stock split between one for 25 and one for 50.

Shareholders voting more than 5 billion shares of Baltia’s 9 billion shares of outstanding common stock approved both proposals. Baltia’s over-the-counter stock was trading at .005 cents Thursday.

At the time, Koulouris said the new name would allow the company to shed “the baggage” associated with Baltia.

The company was founded in 1989 to offer the first non-stop flights between JFK and St. Petersburg, Russia, but it had no planes and never flew anywhere. The SEC ultimately charged its former vice president for finance with running the inequivalent of an in-house brokerage to sell $26 million in unregistered common stock.













FacebookTwitterLinkedInCopy LinkMore

Subscribe To Investors Hangout On YouTube For Daily Stock Analysis Videos!
(Click Here)
(2) (0) Live Stock Analysis



Read More: https://investorshangout.com/post/view?id=464...z4mHKk3cje
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 29

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 22

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 28

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 16

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 23

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 22

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 22

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 17

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 24

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading

Top 5 Most Recently Viewed Articles

AI Revolutionizes Trading: Insights from FBS Analysts

Updated Category News Views 358

AI's Impact on Trading: Key Developments and Insights In recent years, artificial intelligence (AI) has significantly influenced various industries, and trading is no exception. FBS, a prominent global broker, has conducted a deep dive into this revolutionary shift. They emphasize how AI is enhancing the efficiency, accuracy, and overall decision-making processes in...

Continue Reading
Alerus Financial Corp: Anticipated Earnings Report Insights

Updated Category News Views 131

Insights into Alerus Financial Corp’s Upcoming Earnings Alerus Finl (NASDAQ: ALRS) is gearing up to share its quarterly earnings report on a forthcoming Monday. Investors are on the edge of their seats, eagerly anticipating insights into the company’s performance and forecasts for the upcoming quarter. Analysts predict that Alerus Finl will achieve an earnings per...

Continue Reading
DXC Technology Unveils London Center to Enhance AI Solutions

Updated Category News Views 133

DXC Technology Unveils New Customer Experience Center in London DXC Technology (NYSE: DXC), a prominent enterprise technology partner, has recently inaugurated its Customer Experience Center in London. This center is set to transform how businesses harness artificial intelligence (AI) by assisting them in moving from merely experimenting with AI technologies to achieving...

Continue Reading
Coave Therapeutics Showcases Innovative Capsid Technology at ESGCT

Updated Category News Views 188

Coave Therapeutics Showcases Innovative Capsid Technology at ESGCT Coave Therapeutics, a leader in genetic medicine innovation, recently presented compelling data regarding its advanced suprachoroidal capsid, coAAV-SCS-01, at the European Society of Gene and Cell Therapy Congress 2025 held in Seville. This innovative capsid has shown to outperform traditional capsids,...

Continue Reading
HealthPRO Canada Celebrates Work Culture Achievement Again

Updated Category News Views 215

HealthPRO Canada's Continued Commitment to Excellence HealthPRO Canada, a prominent provider of group contracting for healthcare, proudly announces its status as a Great Place to Work® for the fourth consecutive year. This recognition highlights the organization’s dedication to fostering a supportive and inclusive work environment. Understanding the Great Place to...

Continue Reading